Company: INVUP
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001193
Chunk: 1581

Company: Investview, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 2
Chunk 1581
---
Our
corporate headquarters consisting of approximately 7,102 square feet of office space are located at 521 West Lancaster Avenue, Second
Floor, Haverford, Pennsylvania 19041 and are being leased under a one-year lease agreement that will expire in December 2025. Our iGenius
LLC headquarters consisting of approximately 1,325 square feet of office space are located at 459 North 300 West, #15, Kaysville, Utah
84037 and is on a month-to-month lease. The manufacturing headquarters consisting of approximately 12,500 square feet of office and manufacturing
space for Renu Laboratories LLC are located at 1836 Stout Drive, #1, 2, 5, 6, and 7, Warminster, Pennsylvania 18974 and are being leased
under a 14-month lease that will expire in December 2025. Additionally, approximately 5,849 square feet of warehouse space for Renu Laboratories
LLC located at 48 Vincent Circle, #48A, Ivyland, Pennsylvania 18974 is being leased for storage of materials and pre-finished goods under
a 2-year lease agreement that will expire in December 2026. Our Opencash Securities LLC headquarters, consisting of approximately 134
square feet of office space, are located at 1120 NASA Parkway, #220C, Houston, Texas, 77058 and is on a one-year lease that will expire
in December 2025. We lease administrative office space, which is located at 386 Main Street, #212, Wyckoff, New Jersey 07481 and is being
leased under a two-year lease agreement that will expire in July 2025 with an option for the Company to terminate with 60 days’
written notice.

Item
3. Legal Proceedings

In
the ordinary course of business, we may be or have been involved in legal proceedings from time to time; however, we do not anticipate
that the outcome of such matters and disputes will materially affect our financial statements.

None
of our directors, officers, or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our
business.

We
are not currently involved in any material legal proceedings. However, during November 2021, we received a subpoena from the United
States Securities and Exchange Commission (“SEC”) for the production of documents. The SEC order, the factual and legal findings
of which we neither admit nor deny, relates to